When was Dalton founded?

Dalton was founded in 1986 and raised its 1st funding round 27 years after it was founded.

Where is Dalton located?

Dalton is headquartered in Toronto, Canada.

How many employees does Dalton have?

As of Jul 31, 2026, the latest employee count at Dalton is 156.

Is Dalton a funded company?

Dalton is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Mar 14, 2013.

When was the latest funding round of Dalton?

Dalton's latest funding was a $***** Grant (prize money) round on Mar 14, 2013, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. Globally, the Biopharma Outsourcing sector has seen $1.18B in funding in 2026 to date.

Where does Dalton rank among its competitors?

Dalton ranks 13th amongst 384 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Almac Group, which secured $417K in Sep, 2022.

Who are the top competitors of Dalton?

Dalton's top competitors include Concord Biotech, Biophore and Almac Group. Among them, Almac Group secured the most recent funding round in September, 2022.

Dalton - 2026 Company Profile, Funding & Competitors

Company Details

Dalton provides drug discovery, development, and manufacturing services to biotechnology and pharmaceutical clients around the world. They manufacture Active Pharmaceutical Ingredients (APIs), sterile injectables, finished drug products in vials or syringes, as well as solid oral dosage forms. APIs can be produced in gram to kilogram quantities, including sterile APIs. It also offers contract services at any stage of the regulatory process (phase I, II, III, or commercial). Development services include chemistry and process development, medicinal chemistry, custom drug conjugation, targeted drug delivery systems, analytical method development and validation, ICH stability testing, formulation, and polymorphism screening.

Website: dalton.com
Email ID: *****@dalton.com
Phone Number: +1 **********

Key Metrics

Founded Year

1986

Location

Toronto, Canada

Stage

Acquired

Latest Funding Round

Grant (prize money), Mar 14, 2013, $*****

Investors

HHS

Ranked

13^th among 384 active competitors

Employee Count

156 as on Jul 31, 2026

Similar Companies

Concord Biotech & 429 more

Exit Details

Acquired by Seikagaku (Apr 15, 2020)

View Dalton's full profile

Dalton got acquired by Seikagaku on Apr 15, 2020.

Click here to take a look at Dalton's acquisition in detail

Dalton has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Mar 14, 2013 for $*****. 1 investor participated in its latest round. Dalton has 1 institutional investor.

Here is the list of recent funding rounds of Dalton:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 14, 2013	6238203	Grant (prize money)	1893989	2199896	2096674	9321115

Access funding benchmarks and valuations. Sign up today!

View details of Dalton's funding rounds and investors

Dalton's employee count trend

Dalton has 156 employees as of Jul 26. Here is Dalton's employee count trend over the years:

Uncover Dalton's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dalton include Concord Biotech, Biophore and Almac Group. Here is the list of Top 10 competitors of Dalton, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Concord Biotech 1984, Ahmedabad (India), Public	CDMO focused on manufacturing API	$11.3M	Quadria Capital, Helix Investments & 18 others	69/100
2nd	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	62/100
3rd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	57/100
4th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
5th	Jagsonpal 1964, Delhi (India), Public	Traditional company manufacturing bulk drugs and finished formulations	-	Convergent, Aresko	53/100
6th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	53/100
7th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
8th	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$16.8M	Zephyr Management, Zephyr Peacock & 39 others	51/100
9th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	51/100
10th	Asymchem 1995, Morrisville (United States), Public	CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally	-	Hillhouse, HSG & 5 others	50/100
13th	Dalton 1986, Toronto (Canada), Acquired	Integrated drug discovery, development and manufacturing services	-	HHS	50/100